1. Home
  2. JVA vs MDCX Comparison

JVA vs MDCX Comparison

Compare JVA & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$4.29

Market Cap

17.8M

ML Signal

HOLD

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$0.33

Market Cap

16.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
MDCX
Founded
1971
2008
Country
United States
United States
Employees
N/A
16
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
16.6M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
JVA
MDCX
Price
$4.29
$0.33
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
34.1K
1.6M
Earning Date
06-12-2026
05-11-2026
Dividend Yield
1.71%
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.48
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.93
$0.25
52 Week High
$5.62
$3.69

Technical Indicators

Market Signals
Indicator
JVA
MDCX
Relative Strength Index (RSI) 45.06 49.84
Support Level $4.08 $0.27
Resistance Level $4.75 $0.36
Average True Range (ATR) 0.19 0.04
MACD -0.02 0.00
Stochastic Oscillator 20.24 42.36

Price Performance

Historical Comparison
JVA
MDCX

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

Share on Social Networks: